Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GATA3
|
ENSG00000107485.18 | GATA binding protein 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GATA3 | hg38_v1_chr10_+_8045345_8045393 | -0.34 | 5.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89213917 | 6.49 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr1_+_26317950 | 5.61 |
ENST00000374213.3
|
CD52
|
CD52 molecule |
chr7_+_142800957 | 5.36 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr2_-_89117844 | 4.75 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr2_+_90159840 | 4.69 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr14_+_22462932 | 4.53 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
chrX_+_129779930 | 4.37 |
ENST00000356892.4
|
SASH3
|
SAM and SH3 domain containing 3 |
chr2_+_89862438 | 3.94 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr2_-_89268506 | 3.90 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr7_+_142791635 | 3.84 |
ENST00000633705.1
|
TRBC1
|
T cell receptor beta constant 1 |
chr14_-_106579223 | 3.77 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr11_+_60455839 | 3.71 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr22_+_22343185 | 3.70 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr2_+_90100235 | 3.66 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr14_-_106038355 | 3.53 |
ENST00000390597.3
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr2_-_89320146 | 3.38 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr3_+_108822778 | 3.33 |
ENST00000295756.11
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr2_+_89913982 | 3.32 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr11_+_118344318 | 3.27 |
ENST00000392883.6
ENST00000532917.3 ENST00000528540.5 |
CD3G
|
CD3g molecule |
chr2_-_88947820 | 3.17 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr16_+_23835946 | 3.13 |
ENST00000321728.12
ENST00000643927.1 |
PRKCB
|
protein kinase C beta |
chr14_-_106511856 | 2.94 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr22_+_22030934 | 2.91 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr19_+_5681140 | 2.90 |
ENST00000579559.1
ENST00000577222.5 |
HSD11B1L
RPL36
|
hydroxysteroid 11-beta dehydrogenase 1 like ribosomal protein L36 |
chr1_-_161631152 | 2.85 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr1_-_161631032 | 2.83 |
ENST00000534776.1
ENST00000613418.4 ENST00000614870.4 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr2_-_89100352 | 2.82 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr2_+_90220727 | 2.75 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr14_-_105987068 | 2.75 |
ENST00000390594.3
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr17_-_36090133 | 2.73 |
ENST00000613922.2
|
CCL3
|
C-C motif chemokine ligand 3 |
chr15_-_21718245 | 2.68 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr16_-_30382805 | 2.67 |
ENST00000321367.7
ENST00000652617.1 |
SEPTIN1
|
septin 1 |
chr14_-_105856183 | 2.65 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
chr14_-_106117159 | 2.64 |
ENST00000390601.3
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 |
chr1_+_153357846 | 2.64 |
ENST00000368738.4
|
S100A9
|
S100 calcium binding protein A9 |
chr4_-_164383986 | 2.62 |
ENST00000507270.5
ENST00000514618.5 ENST00000503008.5 |
MARCHF1
|
membrane associated ring-CH-type finger 1 |
chr14_-_105940235 | 2.58 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr12_-_7936177 | 2.57 |
ENST00000544291.1
ENST00000075120.12 |
SLC2A3
|
solute carrier family 2 member 3 |
chr22_+_22792485 | 2.50 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr22_+_22811737 | 2.49 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr2_+_90154073 | 2.49 |
ENST00000611391.1
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr20_+_24949256 | 2.48 |
ENST00000480798.2
|
CST7
|
cystatin F |
chr7_+_142626642 | 2.41 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
chr22_+_22409755 | 2.37 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr14_-_24609660 | 2.35 |
ENST00000557220.6
ENST00000216338.9 ENST00000382548.4 |
GZMH
|
granzyme H |
chr2_+_89851723 | 2.34 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr5_+_157180816 | 2.30 |
ENST00000422843.8
|
ITK
|
IL2 inducible T cell kinase |
chr12_-_57488726 | 2.29 |
ENST00000550288.6
ENST00000393797.7 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chr17_-_39864304 | 2.29 |
ENST00000346872.8
|
IKZF3
|
IKAROS family zinc finger 3 |
chrX_+_130171903 | 2.28 |
ENST00000257017.5
|
RAB33A
|
RAB33A, member RAS oncogene family |
chr12_-_54295748 | 2.28 |
ENST00000540264.2
ENST00000312156.8 |
NFE2
|
nuclear factor, erythroid 2 |
chr3_+_108822759 | 2.26 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr2_-_88857582 | 2.26 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr14_-_106771020 | 2.26 |
ENST00000617374.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr4_-_83109843 | 2.23 |
ENST00000411416.6
|
PLAC8
|
placenta associated 8 |
chr14_-_105743032 | 2.22 |
ENST00000390548.6
ENST00000390549.6 ENST00000390542.6 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr1_-_161549793 | 2.22 |
ENST00000443193.6
|
FCGR3A
|
Fc fragment of IgG receptor IIIa |
chr20_+_46021665 | 2.22 |
ENST00000454036.6
ENST00000628272.1 ENST00000626701.1 ENST00000413737.2 |
SLC12A5
|
solute carrier family 12 member 5 |
chrX_+_71144818 | 2.21 |
ENST00000536169.5
ENST00000358741.4 ENST00000395855.6 ENST00000374051.7 |
NLGN3
|
neuroligin 3 |
chr22_-_37149900 | 2.21 |
ENST00000216223.10
|
IL2RB
|
interleukin 2 receptor subunit beta |
chr11_-_118342691 | 2.20 |
ENST00000300692.9
|
CD3D
|
CD3d molecule |
chr7_+_142740206 | 2.18 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
chr22_+_22758698 | 2.15 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr4_+_73740541 | 2.14 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr7_-_38249572 | 2.12 |
ENST00000436911.6
|
TRGC2
|
T cell receptor gamma constant 2 |
chr14_-_106277039 | 2.12 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr17_-_44911281 | 2.11 |
ENST00000638304.1
ENST00000591880.2 ENST00000586125.2 ENST00000639921.1 |
GFAP
|
glial fibrillary acidic protein |
chr1_-_161549892 | 2.11 |
ENST00000426740.7
|
FCGR3A
|
Fc fragment of IgG receptor IIIa |
chr14_-_106422175 | 2.09 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr2_-_89040745 | 2.05 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr3_+_48223325 | 2.02 |
ENST00000296435.2
|
CAMP
|
cathelicidin antimicrobial peptide |
chr5_-_39274515 | 1.99 |
ENST00000510188.1
|
FYB1
|
FYN binding protein 1 |
chr14_-_105771405 | 1.98 |
ENST00000641136.1
ENST00000390551.6 |
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chrX_+_124346544 | 1.97 |
ENST00000371139.9
|
SH2D1A
|
SH2 domain containing 1A |
chr6_-_32192845 | 1.95 |
ENST00000487761.5
|
GPSM3
|
G protein signaling modulator 3 |
chr15_+_58138169 | 1.93 |
ENST00000558772.5
|
AQP9
|
aquaporin 9 |
chr7_-_3043838 | 1.93 |
ENST00000356408.3
ENST00000396946.9 |
CARD11
|
caspase recruitment domain family member 11 |
chr9_-_35618367 | 1.91 |
ENST00000378431.5
ENST00000378430.3 ENST00000259633.9 |
CD72
|
CD72 molecule |
chr15_+_58138368 | 1.90 |
ENST00000219919.9
ENST00000536493.1 |
AQP9
|
aquaporin 9 |
chr7_+_142345412 | 1.90 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
chr12_-_11269696 | 1.88 |
ENST00000381842.7
|
PRB3
|
proline rich protein BstNI subfamily 3 |
chr11_+_124739927 | 1.88 |
ENST00000284292.11
ENST00000412681.2 |
NRGN
|
neurogranin |
chr6_+_35297809 | 1.84 |
ENST00000316637.7
|
DEF6
|
DEF6 guanine nucleotide exchange factor |
chr6_-_132757883 | 1.84 |
ENST00000525289.5
ENST00000326499.11 |
VNN2
|
vanin 2 |
chr14_+_22123318 | 1.84 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr5_+_169695135 | 1.82 |
ENST00000523684.5
ENST00000519734.5 |
DOCK2
|
dedicator of cytokinesis 2 |
chr6_-_41747390 | 1.82 |
ENST00000356667.8
ENST00000373025.7 ENST00000425343.6 |
PGC
|
progastricsin |
chr11_-_118342645 | 1.81 |
ENST00000529594.5
|
CD3D
|
CD3d molecule |
chr12_+_85874287 | 1.81 |
ENST00000551529.5
ENST00000256010.7 |
NTS
|
neurotensin |
chr14_-_106791226 | 1.79 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr22_+_22711689 | 1.79 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr1_+_66354375 | 1.78 |
ENST00000480109.2
|
PDE4B
|
phosphodiesterase 4B |
chr5_-_50441350 | 1.77 |
ENST00000508934.5
|
EMB
|
embigin |
chr6_-_36757380 | 1.76 |
ENST00000393189.2
|
CPNE5
|
copine 5 |
chr2_+_90021567 | 1.76 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr5_+_170232912 | 1.76 |
ENST00000524171.5
ENST00000517575.4 ENST00000518395.2 ENST00000593851.5 |
C5orf58
|
chromosome 5 open reading frame 58 |
chr3_+_138010143 | 1.76 |
ENST00000183605.10
|
CLDN18
|
claudin 18 |
chr14_-_106557465 | 1.75 |
ENST00000390625.3
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr11_+_35180279 | 1.75 |
ENST00000531873.5
|
CD44
|
CD44 molecule (Indian blood group) |
chr3_+_114294020 | 1.73 |
ENST00000383671.8
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains |
chr17_-_75844334 | 1.73 |
ENST00000592386.5
ENST00000412096.6 ENST00000586147.1 ENST00000207549.9 |
UNC13D
|
unc-13 homolog D |
chr12_-_11310420 | 1.73 |
ENST00000621732.4
ENST00000445719.2 ENST00000279575.7 |
PRB4
|
proline rich protein BstNI subfamily 4 |
chr1_+_44674688 | 1.73 |
ENST00000418644.5
ENST00000458657.6 ENST00000535358.6 ENST00000441519.5 ENST00000445071.5 |
ARMH1
|
armadillo like helical domain containing 1 |
chr2_+_113406368 | 1.72 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr22_+_22922594 | 1.71 |
ENST00000390331.3
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr4_-_163613505 | 1.70 |
ENST00000339875.9
|
MARCHF1
|
membrane associated ring-CH-type finger 1 |
chr6_+_6588082 | 1.69 |
ENST00000379953.6
|
LY86
|
lymphocyte antigen 86 |
chr13_-_46168495 | 1.69 |
ENST00000416500.5
|
LCP1
|
lymphocyte cytosolic protein 1 |
chr14_-_106154113 | 1.69 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr2_+_90082635 | 1.69 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr5_-_39270623 | 1.69 |
ENST00000512138.1
ENST00000646045.2 |
FYB1
|
FYN binding protein 1 |
chr17_+_7336502 | 1.69 |
ENST00000158762.8
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr8_+_103140692 | 1.68 |
ENST00000438105.2
ENST00000309982.10 ENST00000297574.6 |
BAALC
|
BAALC binder of MAP3K1 and KLF4 |
chr17_-_36196748 | 1.67 |
ENST00000619989.1
|
CCL3L1
|
C-C motif chemokine ligand 3 like 1 |
chr22_-_37244417 | 1.66 |
ENST00000405484.5
ENST00000441619.5 ENST00000406508.5 |
RAC2
|
Rac family small GTPase 2 |
chr7_+_142592928 | 1.65 |
ENST00000616518.1
|
TRBV15
|
T cell receptor beta variable 15 |
chr1_+_32251239 | 1.65 |
ENST00000373564.7
ENST00000482949.5 ENST00000336890.10 ENST00000495610.6 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr12_-_54984667 | 1.63 |
ENST00000524668.5
ENST00000533607.1 ENST00000449076.6 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr17_-_39864140 | 1.62 |
ENST00000623724.3
ENST00000439167.6 ENST00000377945.7 ENST00000394189.6 ENST00000377944.7 ENST00000377958.6 ENST00000535189.5 ENST00000377952.6 |
IKZF3
|
IKAROS family zinc finger 3 |
chr2_-_88966767 | 1.62 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr13_+_42574145 | 1.62 |
ENST00000398795.7
ENST00000544862.5 ENST00000239849.8 |
TNFSF11
|
TNF superfamily member 11 |
chr14_-_106108453 | 1.61 |
ENST00000632950.2
|
IGHV5-10-1
|
immunoglobulin heavy variable 5-10-1 |
chr11_-_64742937 | 1.60 |
ENST00000394428.5
ENST00000394429.5 |
RASGRP2
|
RAS guanyl releasing protein 2 |
chr19_-_54100792 | 1.59 |
ENST00000391761.5
ENST00000356532.7 ENST00000616447.4 ENST00000359649.8 ENST00000358375.8 ENST00000391760.1 ENST00000351806.8 |
OSCAR
|
osteoclast associated Ig-like receptor |
chr5_+_55024250 | 1.59 |
ENST00000231009.3
|
GZMK
|
granzyme K |
chr11_-_118342616 | 1.59 |
ENST00000392884.2
|
CD3D
|
CD3d molecule |
chr19_+_7677082 | 1.59 |
ENST00000597445.1
|
MCEMP1
|
mast cell expressed membrane protein 1 |
chrX_-_49264668 | 1.58 |
ENST00000455775.7
ENST00000652559.1 ENST00000376207.10 ENST00000557224.6 ENST00000684155.1 ENST00000376199.7 |
FOXP3
|
forkhead box P3 |
chr9_-_34381531 | 1.56 |
ENST00000379124.5
ENST00000379126.7 ENST00000379127.1 |
C9orf24
|
chromosome 9 open reading frame 24 |
chr6_+_6588708 | 1.56 |
ENST00000230568.5
|
LY86
|
lymphocyte antigen 86 |
chr6_-_31592952 | 1.55 |
ENST00000376073.8
ENST00000376072.7 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr14_-_106675544 | 1.54 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr15_-_79971164 | 1.54 |
ENST00000335661.6
ENST00000267953.4 ENST00000677151.1 |
BCL2A1
|
BCL2 related protein A1 |
chr6_-_41286665 | 1.53 |
ENST00000589614.5
ENST00000244709.9 ENST00000334475.10 ENST00000591620.1 |
TREM1
|
triggering receptor expressed on myeloid cells 1 |
chr11_-_5227063 | 1.53 |
ENST00000335295.4
ENST00000485743.1 ENST00000647020.1 |
HBB
|
hemoglobin subunit beta |
chr14_-_106724093 | 1.53 |
ENST00000390634.3
|
IGHV2-70D
|
immunoglobulin heavy variable 2-70D |
chr22_+_22668286 | 1.53 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr4_+_99816797 | 1.52 |
ENST00000512369.2
ENST00000296414.11 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
chrX_-_154653579 | 1.51 |
ENST00000247306.4
ENST00000369585.4 |
CTAG2
|
cancer/testis antigen 2 |
chr19_+_54630960 | 1.51 |
ENST00000396317.5
ENST00000396315.5 |
LILRB1
|
leukocyte immunoglobulin like receptor B1 |
chr4_-_89835617 | 1.51 |
ENST00000611107.1
ENST00000345009.8 ENST00000505199.5 ENST00000502987.5 |
SNCA
|
synuclein alpha |
chr15_-_44676888 | 1.50 |
ENST00000434130.6
ENST00000560780.1 |
PATL2
|
PAT1 homolog 2 |
chr7_+_74209989 | 1.50 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
chr2_-_88992903 | 1.50 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr16_+_83968244 | 1.49 |
ENST00000305202.9
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
chr2_+_88885397 | 1.49 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr17_+_7336557 | 1.49 |
ENST00000570457.6
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr22_+_22375984 | 1.49 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr1_-_162412117 | 1.48 |
ENST00000367929.3
|
SH2D1B
|
SH2 domain containing 1B |
chr20_+_43916142 | 1.47 |
ENST00000423191.6
ENST00000372999.5 |
TOX2
|
TOX high mobility group box family member 2 |
chr9_+_136977496 | 1.47 |
ENST00000371625.8
ENST00000457950.5 |
PTGDS
|
prostaglandin D2 synthase |
chr10_-_6062290 | 1.47 |
ENST00000256876.10
ENST00000379954.5 |
IL2RA
|
interleukin 2 receptor subunit alpha |
chr22_-_30266839 | 1.47 |
ENST00000403463.1
ENST00000215781.3 |
OSM
|
oncostatin M |
chr19_-_54313074 | 1.47 |
ENST00000486742.2
ENST00000432233.8 |
LILRA5
|
leukocyte immunoglobulin like receptor A5 |
chr6_+_31587185 | 1.45 |
ENST00000376092.7
ENST00000376086.7 ENST00000303757.12 ENST00000376093.6 |
LST1
|
leukocyte specific transcript 1 |
chr12_-_11395556 | 1.45 |
ENST00000565533.1
ENST00000389362.6 ENST00000546254.3 |
PRB2
PRB1
|
proline rich protein BstNI subfamily 2 proline rich protein BstNI subfamily 1 |
chr1_+_207104226 | 1.45 |
ENST00000367070.8
|
C4BPA
|
complement component 4 binding protein alpha |
chr3_-_3110347 | 1.44 |
ENST00000383846.5
ENST00000427088.1 ENST00000446632.7 ENST00000418488.6 ENST00000438560.5 |
IL5RA
|
interleukin 5 receptor subunit alpha |
chr16_+_33009175 | 1.44 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr9_+_110668779 | 1.44 |
ENST00000416899.7
ENST00000374448.9 |
MUSK
|
muscle associated receptor tyrosine kinase |
chr2_+_90038848 | 1.44 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chrX_+_103776493 | 1.44 |
ENST00000433491.5
ENST00000612423.4 ENST00000443502.5 |
PLP1
|
proteolipid protein 1 |
chr4_-_73988179 | 1.44 |
ENST00000296028.4
|
PPBP
|
pro-platelet basic protein |
chr4_-_5019437 | 1.43 |
ENST00000506508.1
ENST00000509419.1 ENST00000307746.9 |
CYTL1
|
cytokine like 1 |
chr14_+_22281097 | 1.43 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr4_+_70226116 | 1.43 |
ENST00000317987.6
|
FDCSP
|
follicular dendritic cell secreted protein |
chr12_-_57479552 | 1.43 |
ENST00000424809.6
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr19_-_38617928 | 1.42 |
ENST00000396857.7
ENST00000586296.5 |
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr5_-_50441244 | 1.42 |
ENST00000303221.10
|
EMB
|
embigin |
chrX_-_101386166 | 1.42 |
ENST00000308731.8
ENST00000372880.5 |
BTK
|
Bruton tyrosine kinase |
chr1_+_155173787 | 1.41 |
ENST00000392451.6
ENST00000545012.5 ENST00000334634.9 ENST00000368385.8 ENST00000543729.5 ENST00000368383.7 ENST00000368382.5 |
TRIM46
|
tripartite motif containing 46 |
chr2_+_227813834 | 1.40 |
ENST00000358813.5
ENST00000409189.7 |
CCL20
|
C-C motif chemokine ligand 20 |
chr5_+_162067500 | 1.40 |
ENST00000639384.1
ENST00000640985.1 ENST00000638772.1 |
GABRG2
|
gamma-aminobutyric acid type A receptor subunit gamma2 |
chr22_+_22895368 | 1.40 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 |
chr17_+_9576627 | 1.39 |
ENST00000396219.7
ENST00000352665.10 |
CFAP52
|
cilia and flagella associated protein 52 |
chr17_-_31314066 | 1.39 |
ENST00000577894.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr1_-_36482904 | 1.39 |
ENST00000373106.6
|
CSF3R
|
colony stimulating factor 3 receptor |
chr6_-_31582415 | 1.38 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
chr2_-_89010515 | 1.38 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr22_+_22431949 | 1.38 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr1_+_198638457 | 1.37 |
ENST00000367379.6
|
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr22_+_22098683 | 1.37 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr16_-_50681289 | 1.37 |
ENST00000423026.6
ENST00000330943.9 |
SNX20
|
sorting nexin 20 |
chr1_+_46671821 | 1.36 |
ENST00000334122.5
ENST00000415500.1 |
TEX38
|
testis expressed 38 |
chr5_+_162067458 | 1.36 |
ENST00000639975.1
ENST00000639111.2 ENST00000639683.1 |
GABRG2
|
gamma-aminobutyric acid type A receptor subunit gamma2 |
chr13_-_46182136 | 1.35 |
ENST00000323076.7
|
LCP1
|
lymphocyte cytosolic protein 1 |
chr12_-_10390023 | 1.35 |
ENST00000240618.11
|
KLRK1
|
killer cell lectin like receptor K1 |
chr5_-_39202991 | 1.35 |
ENST00000515010.5
|
FYB1
|
FYN binding protein 1 |
chr1_+_206406377 | 1.35 |
ENST00000605476.5
|
SRGAP2
|
SLIT-ROBO Rho GTPase activating protein 2 |
chr2_+_89884740 | 1.34 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr2_+_186694076 | 1.34 |
ENST00000612606.1
|
FAM171B
|
family with sequence similarity 171 member B |
chr22_-_37244237 | 1.33 |
ENST00000401529.3
ENST00000249071.11 |
RAC2
|
Rac family small GTPase 2 |
chr2_-_89085787 | 1.33 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr1_-_89270751 | 1.33 |
ENST00000370459.7
|
GBP5
|
guanylate binding protein 5 |
chr11_-_118212885 | 1.33 |
ENST00000524477.5
|
JAML
|
junction adhesion molecule like |
chr5_-_157575767 | 1.33 |
ENST00000257527.9
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr16_-_11281322 | 1.33 |
ENST00000312511.4
|
PRM1
|
protamine 1 |
chr11_-_47378391 | 1.32 |
ENST00000227163.8
|
SPI1
|
Spi-1 proto-oncogene |
chr3_-_50345665 | 1.32 |
ENST00000442887.1
ENST00000231749.8 ENST00000360165.7 |
ZMYND10
|
zinc finger MYND-type containing 10 |
chr14_+_23376765 | 1.32 |
ENST00000649278.1
|
CMTM5
|
CKLF like MARVEL transmembrane domain containing 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.9 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.9 | 2.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 2.5 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.8 | 140.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 5.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 3.0 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.7 | 5.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.7 | 2.1 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.7 | 4.1 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.7 | 3.3 | GO:0002357 | defense response to tumor cell(GO:0002357) |
0.6 | 4.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 1.9 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.6 | 2.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.6 | 1.8 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.6 | 3.0 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.6 | 3.5 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 1.7 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 5.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.6 | 1.7 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.6 | 2.2 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.5 | 2.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.6 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.5 | 2.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 2.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.5 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 0.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 1.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.5 | 1.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.5 | 1.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.5 | 2.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.5 | 7.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.5 | 1.5 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.5 | 1.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.5 | 1.4 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.5 | 0.5 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.5 | 4.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.5 | 1.4 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.5 | 1.4 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.4 | 1.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.4 | 2.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 5.3 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.4 | 2.6 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 2.1 | GO:1904021 | negative regulation of G-protein coupled receptor internalization(GO:1904021) |
0.4 | 1.7 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.4 | 1.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.4 | 1.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 1.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 1.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.4 | 2.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 3.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 1.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.4 | 3.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 2.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.4 | 3.1 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.4 | 1.9 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.4 | 3.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.4 | 2.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 1.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.4 | 1.1 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.4 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 11.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 1.1 | GO:2000566 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 | 3.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 1.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 2.8 | GO:0051610 | serotonin uptake(GO:0051610) |
0.4 | 9.5 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.3 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 2.0 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.3 | 0.7 | GO:0002876 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
0.3 | 2.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 1.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.3 | 2.0 | GO:0098759 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.3 | 1.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.3 | 1.0 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 2.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 1.3 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.3 | 0.9 | GO:0036290 | protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
0.3 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.9 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 0.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.3 | 1.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 1.2 | GO:0072560 | type B pancreatic cell maturation(GO:0072560) |
0.3 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.2 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.3 | 1.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.3 | 1.5 | GO:0032796 | uropod organization(GO:0032796) |
0.3 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 0.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 2.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.3 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.3 | 0.9 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.3 | 0.3 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.3 | 1.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.3 | 4.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.3 | 0.6 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.3 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.6 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.3 | 0.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.3 | 1.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.3 | 1.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.3 | 1.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 7.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 55.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.8 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.3 | 1.8 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) |
0.3 | 1.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.3 | 0.8 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.3 | 3.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 1.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.3 | 5.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 0.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 7.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 1.0 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.2 | 0.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.5 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.2 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.7 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 0.7 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.2 | 8.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 0.9 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.7 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 1.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.2 | 0.7 | GO:1904253 | lipid transport involved in lipid storage(GO:0010877) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.2 | 3.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.9 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.2 | 0.7 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 5.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.7 | GO:2000506 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) negative regulation of energy homeostasis(GO:2000506) |
0.2 | 0.9 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.2 | 2.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 0.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 0.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 0.6 | GO:0002883 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) regulation of hypersensitivity(GO:0002883) negative regulation of hypersensitivity(GO:0002884) |
0.2 | 0.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.2 | 4.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.2 | GO:0021816 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.2 | 2.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 1.9 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
0.2 | 0.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.2 | 4.9 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 0.2 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
0.2 | 0.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.2 | 3.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.6 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.2 | 0.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.8 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.2 | 2.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.2 | 1.6 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.2 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.2 | 2.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.2 | 1.0 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.2 | 1.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.8 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.2 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.6 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.2 | 1.3 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.2 | 0.6 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
0.2 | 0.6 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.2 | 2.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.4 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 0.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 1.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 3.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.9 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 1.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 2.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 0.8 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.5 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.2 | 1.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 2.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.3 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.6 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.2 | 1.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 0.9 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 3.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 4.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.5 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
0.2 | 0.6 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.2 | 0.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 1.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 1.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.8 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 24.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 2.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 2.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 3.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.5 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.1 | 0.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 1.2 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 1.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 3.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 1.7 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 2.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 11.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.4 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 3.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 1.0 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 2.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.7 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 1.7 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.3 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 1.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.1 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 2.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.8 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 0.7 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.1 | 0.3 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.1 | GO:0035566 | regulation of metanephros size(GO:0035566) |
0.1 | 2.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 2.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 3.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.4 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
0.1 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.5 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 1.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 1.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 1.5 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 0.2 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.1 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 2.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.2 | GO:0060440 | trachea formation(GO:0060440) |
0.1 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 2.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.1 | 0.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.1 | 0.6 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 2.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 5.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 3.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 4.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.2 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.2 | GO:0032497 | lipopolysaccharide transport(GO:0015920) detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.3 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 2.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 7.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 2.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 0.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 1.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.3 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.1 | 1.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 1.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.9 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.1 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.3 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.6 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.1 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 9.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.5 | GO:0052053 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.1 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 4.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.3 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.3 | GO:0050976 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.1 | 3.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 1.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:0090095 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 3.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.2 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.1 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.6 | GO:1903412 | response to bile acid(GO:1903412) |
0.1 | 1.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 4.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.3 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 2.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 2.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.8 | GO:0061419 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.5 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.3 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 1.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.1 | GO:0009631 | cold acclimation(GO:0009631) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 3.9 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.1 | GO:0072144 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 4.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.1 | 0.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.2 | GO:0015734 | taurine transport(GO:0015734) |
0.1 | 0.5 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 5.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 3.0 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 9.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.4 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.5 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
0.1 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 0.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 | 2.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.2 | GO:0061027 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
0.1 | 0.5 | GO:0010813 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.1 | 0.2 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 2.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.2 | GO:2001170 | peptidyl-serine ADP-ribosylation(GO:0018312) negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 2.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.1 | 0.5 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.2 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.1 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 1.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 2.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.9 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.3 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 1.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 1.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 1.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 1.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.8 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 2.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 1.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.1 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.4 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 1.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.3 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.6 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.5 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.2 | GO:2001202 | negative regulation of transforming growth factor-beta secretion(GO:2001202) |
0.1 | 1.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 1.9 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 1.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.5 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.3 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.1 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.7 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 1.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 9.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 1.9 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 3.8 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.0 | 1.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.5 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.2 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.0 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 1.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.2 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.7 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.0 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.4 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.5 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:1904058 | positive regulation of gastric acid secretion(GO:0060454) positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.9 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.0 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.0 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.0 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.0 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 1.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.2 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.3 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.4 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.5 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 0.0 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.0 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 2.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 3.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.6 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.1 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0006463 | steroid hormone receptor complex assembly(GO:0006463) |
0.0 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.4 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.1 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.9 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 2.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.1 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.9 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.1 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.0 | 0.1 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.1 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) axial mesoderm development(GO:0048318) |
0.0 | 1.4 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:1902913 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.9 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.6 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.0 | 0.0 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.0 | 0.2 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0051446 | meiotic cell cycle phase transition(GO:0044771) positive regulation of meiotic cell cycle(GO:0051446) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.0 | 0.1 | GO:0019086 | early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
0.0 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 1.3 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.3 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.8 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:1901656 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
0.0 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 1.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.2 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.0 | 0.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.0 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.0 | 0.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0052490 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.0 | 0.1 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.5 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 1.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.0 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.0 | GO:0006863 | purine nucleobase transport(GO:0006863) |
0.0 | 0.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 65.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.0 | 11.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 2.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 1.4 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.5 | 4.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 4.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.4 | 9.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 2.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 3.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 4.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 1.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.9 | GO:1990332 | Ire1 complex(GO:1990332) |
0.3 | 1.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 5.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.3 | 1.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.3 | 1.7 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 1.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.3 | 1.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 1.9 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
0.3 | 1.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 4.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 10.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 4.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.7 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 6.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.2 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.2 | 2.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 3.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 7.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.2 | 0.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 1.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.6 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 1.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.4 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 15.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 28.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 2.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.1 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 3.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 3.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 2.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 3.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 5.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 7.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.4 | GO:1990879 | CST complex(GO:1990879) |
0.1 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 14.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 7.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 30.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 3.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.1 | 1.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 14.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 1.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 1.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.1 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 0.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.2 | GO:1990696 | stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 5.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.6 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 9.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0032473 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
0.1 | 0.6 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.2 | GO:0070701 | mucus layer(GO:0070701) |
0.1 | 2.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 0.1 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.7 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 5.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 6.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.2 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 1.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 3.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 3.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.0 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 1.7 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 8.0 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 3.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 1.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 4.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 2.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 1.7 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 2.9 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 1.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 2.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.1 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 1.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 23.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 3.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 5.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.1 | 5.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.9 | 66.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.8 | 3.9 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
0.7 | 2.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.7 | 4.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.7 | 12.3 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 3.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 3.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.6 | 125.2 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 2.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 2.5 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.5 | 2.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.5 | 3.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.5 | 3.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.5 | 1.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.5 | 7.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 4.7 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.5 | 3.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 6.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 2.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 1.2 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.4 | 1.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.3 | 2.0 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.3 | 1.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 3.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 6.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.3 | 1.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 0.9 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.3 | 1.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.3 | 3.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 2.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 0.9 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.3 | 0.8 | GO:0099530 | G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.3 | 3.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.8 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.3 | 4.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 0.8 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.3 | 2.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 2.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 5.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.5 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.3 | 2.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 3.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.5 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 2.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 2.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.7 | GO:0035375 | zymogen binding(GO:0035375) |
0.2 | 0.7 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.2 | 3.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 2.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.6 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.2 | 0.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 4.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 1.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.6 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.2 | 3.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 0.6 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 3.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 0.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.2 | GO:0023029 | peptide antigen-transporting ATPase activity(GO:0015433) MHC class Ib protein binding(GO:0023029) TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.2 | 1.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 1.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 5.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.2 | 5.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.9 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.6 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 0.9 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.2 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 3.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 4.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 3.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 2.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 4.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 2.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 4.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 4.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 2.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 6.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 6.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 1.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 0.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 6.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 2.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 2.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 3.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 1.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 2.0 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 2.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 12.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 5.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.1 | 3.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 5.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 2.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.7 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.3 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 1.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.1 | 4.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 5.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 3.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 2.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 1.0 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 2.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.1 | 0.3 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.2 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.2 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
0.1 | 0.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.1 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 1.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 5.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 12.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 3.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.7 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 0.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.0 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.0 | 0.2 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.0 | 1.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.0 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.0 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.0 | 0.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.0 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 7.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 2.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
0.0 | 12.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 8.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 1.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:1901474 | thiamine transmembrane transporter activity(GO:0015234) azole transmembrane transporter activity(GO:1901474) |
0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 7.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.0 | 0.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.0 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 1.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0034191 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.0 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 23.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 9.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 12.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 3.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 13.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 15.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 5.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 8.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 5.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 4.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 8.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 9.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 4.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 5.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 9.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 6.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 10.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 4.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 6.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 2.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 2.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 2.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.7 | 15.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.7 | 0.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 4.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 8.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 6.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 23.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 3.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 16.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 9.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 7.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 25.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 5.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 6.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 6.4 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 4.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 4.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 4.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 5.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 4.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 11.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 3.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 3.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 2.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.7 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 5.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 8.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 2.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 2.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 4.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.6 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 3.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 5.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 1.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.7 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 1.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |